drugset / Trial / NCT00417677
A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study is being conducted to determine the Maximum Tolerated Dose (MTD) and efficacy of the combined treatment of Temsirolimus and Sunitinib for the treatment of Advanced Kidney Cancer
Timeline
- Start
- 2007-03
- Primary completion
- —
- Completion
- 2007-05
Outcome
Outcome not reported
Stopped: “Decision was made not to attempt a lower dose”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sunitinib | Small molecule | — | — |
| Subject | Temsirolimus | Small molecule | — | — |